Cargando…
Development of AB(3)-Type Novel Phthalocyanine and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium for Higher Photodynamic Efficacy
[Image: see text] There are a number of lipophilic cations that can be chosen; the triphenylphosphonium (TPP) ion is particularly unique for mitochondrion targeting, mainly due to its simplicity in structure and ease to be linked to the target molecules. In this work, mitochondrion-targeted AB(3)-ty...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631755/ https://www.ncbi.nlm.nih.gov/pubmed/36340065 http://dx.doi.org/10.1021/acsomega.2c05814 |
_version_ | 1784823885498155008 |
---|---|
author | Önal, Emel Tüncel, Özge Erdoğan Vatansever, İpek Albakour, Mohamad Gümüşgöz Çelik, Gizem Küçük, Tuğba Akgül, Bünyamin Gürek, Ayşe Gül Özçelik, Serdar |
author_facet | Önal, Emel Tüncel, Özge Erdoğan Vatansever, İpek Albakour, Mohamad Gümüşgöz Çelik, Gizem Küçük, Tuğba Akgül, Bünyamin Gürek, Ayşe Gül Özçelik, Serdar |
author_sort | Önal, Emel |
collection | PubMed |
description | [Image: see text] There are a number of lipophilic cations that can be chosen; the triphenylphosphonium (TPP) ion is particularly unique for mitochondrion targeting, mainly due to its simplicity in structure and ease to be linked to the target molecules. In this work, mitochondrion-targeted AB(3)-type novel phthalocyanine and porphyrin photosensitizers (PSs) were synthesized and their photophysical photochemical properties were defined. Fluorescence quantum yields (Φ(F)) are 0.009, 0.14, 0.13, and 0.13, and the singlet-oxygen quantum yields (Φ(Δ)) are 0.27, 0.75, 0.57, and 0.58 for LuPcPox(OAc), AB(3)TPP-Pc, AB(3)TPP-Por-C4, and AB(3)TPP-Por-C6, respectively. To evaluate the photodynamic efficacy of the TPP-conjugated PS cell viabilities of A549 and BEAS-2B lung cells were comparatively measured and IC-50 values were determined. AB(3)TPP-Por-C4, AB(3)TPP-Por-C6, and AB(3)TPP-Pc compounds compared to the reference molecules ZnPc and H(2)TPP were found to be highly cytotoxic (sub-micromolar concentration) under the light. LuPcPox(OAc) is the most effective molecule regarding cell killing (the activity). The cell killing of the TPP-conjugated porphyrin derivatives exhibits a similar response compared to LuPcPox(OAc) when the light absorbing factor of the PS is normalized at 660 nm: TPP-conjugated porphyrins absorb less light (lower extinction coefficient) but produce more radical species (higher singlet-oxygen quantum yield) and therefore effectively kill the cells. The singlet oxygen-producing capacity of AB(3)TPP-Pc is almost 3 times higher compared to LuPcPox(OAc) and 50% more efficient with respect to ZnPc, suggesting that TPP-conjugated phthalocyanine may serve as a good photosensitizer for photodynamic therapy (PDT). The high singlet oxygen generation capacity of these novel TPP-conjugated porphyrin and phthalocyanine PS suggests that they might be useful for PDT requiring lower photosensitizer concentration and reduced energy deposited through less light exposure. |
format | Online Article Text |
id | pubmed-9631755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-96317552022-11-04 Development of AB(3)-Type Novel Phthalocyanine and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium for Higher Photodynamic Efficacy Önal, Emel Tüncel, Özge Erdoğan Vatansever, İpek Albakour, Mohamad Gümüşgöz Çelik, Gizem Küçük, Tuğba Akgül, Bünyamin Gürek, Ayşe Gül Özçelik, Serdar ACS Omega [Image: see text] There are a number of lipophilic cations that can be chosen; the triphenylphosphonium (TPP) ion is particularly unique for mitochondrion targeting, mainly due to its simplicity in structure and ease to be linked to the target molecules. In this work, mitochondrion-targeted AB(3)-type novel phthalocyanine and porphyrin photosensitizers (PSs) were synthesized and their photophysical photochemical properties were defined. Fluorescence quantum yields (Φ(F)) are 0.009, 0.14, 0.13, and 0.13, and the singlet-oxygen quantum yields (Φ(Δ)) are 0.27, 0.75, 0.57, and 0.58 for LuPcPox(OAc), AB(3)TPP-Pc, AB(3)TPP-Por-C4, and AB(3)TPP-Por-C6, respectively. To evaluate the photodynamic efficacy of the TPP-conjugated PS cell viabilities of A549 and BEAS-2B lung cells were comparatively measured and IC-50 values were determined. AB(3)TPP-Por-C4, AB(3)TPP-Por-C6, and AB(3)TPP-Pc compounds compared to the reference molecules ZnPc and H(2)TPP were found to be highly cytotoxic (sub-micromolar concentration) under the light. LuPcPox(OAc) is the most effective molecule regarding cell killing (the activity). The cell killing of the TPP-conjugated porphyrin derivatives exhibits a similar response compared to LuPcPox(OAc) when the light absorbing factor of the PS is normalized at 660 nm: TPP-conjugated porphyrins absorb less light (lower extinction coefficient) but produce more radical species (higher singlet-oxygen quantum yield) and therefore effectively kill the cells. The singlet oxygen-producing capacity of AB(3)TPP-Pc is almost 3 times higher compared to LuPcPox(OAc) and 50% more efficient with respect to ZnPc, suggesting that TPP-conjugated phthalocyanine may serve as a good photosensitizer for photodynamic therapy (PDT). The high singlet oxygen generation capacity of these novel TPP-conjugated porphyrin and phthalocyanine PS suggests that they might be useful for PDT requiring lower photosensitizer concentration and reduced energy deposited through less light exposure. American Chemical Society 2022-10-19 /pmc/articles/PMC9631755/ /pubmed/36340065 http://dx.doi.org/10.1021/acsomega.2c05814 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Önal, Emel Tüncel, Özge Erdoğan Vatansever, İpek Albakour, Mohamad Gümüşgöz Çelik, Gizem Küçük, Tuğba Akgül, Bünyamin Gürek, Ayşe Gül Özçelik, Serdar Development of AB(3)-Type Novel Phthalocyanine and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium for Higher Photodynamic Efficacy |
title | Development of
AB(3)-Type Novel Phthalocyanine
and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium
for Higher Photodynamic Efficacy |
title_full | Development of
AB(3)-Type Novel Phthalocyanine
and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium
for Higher Photodynamic Efficacy |
title_fullStr | Development of
AB(3)-Type Novel Phthalocyanine
and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium
for Higher Photodynamic Efficacy |
title_full_unstemmed | Development of
AB(3)-Type Novel Phthalocyanine
and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium
for Higher Photodynamic Efficacy |
title_short | Development of
AB(3)-Type Novel Phthalocyanine
and Porphyrin Photosensitizers Conjugated with Triphenylphosphonium
for Higher Photodynamic Efficacy |
title_sort | development of
ab(3)-type novel phthalocyanine
and porphyrin photosensitizers conjugated with triphenylphosphonium
for higher photodynamic efficacy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631755/ https://www.ncbi.nlm.nih.gov/pubmed/36340065 http://dx.doi.org/10.1021/acsomega.2c05814 |
work_keys_str_mv | AT onalemel developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT tuncelozge developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT erdoganvatanseveripek developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT albakourmohamad developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT gumusgozcelikgizem developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT kucuktugba developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT akgulbunyamin developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT gurekaysegul developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy AT ozcelikserdar developmentofab3typenovelphthalocyanineandporphyrinphotosensitizersconjugatedwithtriphenylphosphoniumforhigherphotodynamicefficacy |